TE_18064
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | CNBD1 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 311.08 |
| Counts of samples | TCGA_tumor:275; TCGA_normal:0; GTEx:0 |
| TSS | chr8(+):87425957 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_18064.1 | CNBD1 | Chimeric | Non-coding | Non-coding | chr8(+):87425958,87426399,87428546,87428613,87471248,87471307,87487588,87487608 |
| teRNA_18064.2 | CNBD1 | Chimeric | Non-coding | Non-coding | chr8(+):87425958,87426399,87428546,87428613,87471248,87471307,87609809,87609854,87610539,87610578,87612006,87612094,87615085,87615105 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
